Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001564590-19-040492
Filing Date
2019-11-05
Accepted
2019-11-05 17:28:18
Documents
12
Period of Report
2019-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A amrn-8ka_20191105.htm   iXBRL 8-K/A 374160
  Complete submission text file 0001564590-19-040492.txt   519639

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA amrn-20191105.xsd EX-101.SCH 5976
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE amrn-20191105_lab.xml EX-101.LAB 20097
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amrn-20191105_pre.xml EX-101.PRE 12042
10 EXTRACTED XBRL INSTANCE DOCUMENT amrn-8ka_20191105_htm.xml XML 4849
Mailing Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000
Business Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-21392 | Film No.: 191194402
SIC: 2834 Pharmaceutical Preparations